Regimen Choice and Newly Approved Agents in Relapsed/Refractory Multiple Myeloma
Watch the webcast of renowned experts actively engaged in the care of patients with multiple myeloma debate topics on treating patients with high-risk smoldering, transplant, optimal approaches to BCMA targeting and much more, held in conjunction with the 2021 Society of Hematology Oncology Annual Meeting. #SOHO2021.
Expires Sep 30, 2022
Faculty
CAR T-Cell Therapy for Lymphoma and Myeloma in Clinical Practice
This webcast features three renowned experts actively engaged in the care of patients with lymphoma and myeloma as they present the most up-to-date information from a symposium that was held in conjunction with the 2021 Society of Hematology Oncology Annual Meeting. #SOHO2021
Expires Sep 28, 2022
Faculty
MD Anderson Cancer Center
Houston, Texas
MD Anderson Cancer Center
Houston, Texas
Massachusetts General Hospital
Boston, Massachusetts
Expert Tumor Board to Address Challenging Cases of Relapsed/Refractory Aggressive and Indolent Lymphomas
This webcast will provide expert interpretation of emerging data and guidance regarding current and emerging therapies for the treatment of patients with various aggressive and indolent lymphoma subtypes held in conjunction with the 2021 Pan Pacific Lymphoma Conference. #PPLC21
Expires Sep 14, 2022
Chair
Faculty
Stanford Cancer Institute
Palo Alto, California
Weill Cornell Medicine
New York, New York
This webcast on The Treatment of Patients with Hematologic Malignancies was presented at the 2021 Pan Pacific Lymphoma Conference and features expert interpretation of emerging data and guidance regarding current and emerging therapies for the treatment of patients with lymphoma and multiple myeloma. #PPLC21
Expires Sep 13, 2022
Chair
Faculty
Hear from 3 renowned experts actively engaged in the care of patients with lymphoma and multiple myeloma from an independent satellite symposium that took place following the 2021 American Society of Clinical Oncology Meeting. #ASCO21
Expires Sep 9, 2022
Chair
Faculty
Hear from 3 renowned experts actively engaged in the care of patients with multiple myeloma from an independent satellite symposium that took place following the 2021 American Society of Clinical Oncology Meeting. #ASCO21
Expires August 4 , 2022
Chair
Faculty
City of Hope Cancer Center
Adjunct Professor, College of Health Solutions, Arizona State University
Houston, Texas
The University of Texas MD Anderson Cancer Center
Houston, Texas
Watch 4 renowned experts actively engaged in the care of patients with multiple myeloma debate topics on treating patients with high-risk smoldering, transplant, optimal approaches to BCMA targeting and much more from the 2021 American Society of Hematology meeting. #ASH2021.
Expires January 15 , 2022
Chair
Faculty
Watch a stimulating and informative conversation about current practices to optimize the use of PARP inhibitors for your patients with ovarian cancer from the September 26, 2020 Oncology Nursing Society virtual symposium
Expires November 18, 2021
Expires November 18 , 2022
